RESMED INC - Common Stock (RMD)

Historical Holders from Q1 2014 to Q3 2025

Symbol
RMD on NYSE
Type / Class
Equity / Common Stock
Shares outstanding
146,467,184
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
91,404,379
Holdings value
$25,010,884,495
% of all portfolios
0.02%
Number of holders
930
Number of buys
447
Number of sells
-393
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of RESMED INC - Common Stock (RMD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 13.66% $5,476,630,365 20,007,417 The Vanguard Group 30 Sep 2025

Institutional Holders of RESMED INC - Common Stock (RMD)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 91,404,379 $25,010,884,495 -$151,624,678 $273.73 930
2025 Q2 92,309,428 $23,802,163,537 -$234,889,310 $258.00 911
2025 Q1 93,341,270 $20,873,665,746 +$659,205,153 $223.85 872
2024 Q4 90,103,150 $20,611,027,939 +$523,118,005 $228.69 863
2024 Q3 86,823,807 $21,178,183,309 +$357,448,956 $244.12 792
2024 Q2 85,413,001 $16,344,246,847 +$454,535,216 $191.42 768
2024 Q1 82,914,769 $16,411,147,126 +$513,359,778 $198.03 710
2023 Q4 80,394,822 $13,829,283,421 -$1,271,808,453 $172.02 680
2023 Q3 87,735,817 $12,964,369,891 -$1,617,256,395 $147.87 648
2023 Q2 95,075,328 $20,771,183,152 -$111,688,592 $218.50 724
2023 Q1 95,323,306 $20,870,559,574 +$76,827,102 $218.99 665
2022 Q4 95,570,997 $19,893,153,622 -$213,631,417 $208.13 717
2022 Q3 96,528,325 $21,085,043,390 -$40,809,623 $218.30 650
2022 Q2 96,423,808 $20,247,886,410 -$216,827,167 $209.63 661
2022 Q1 97,272,612 $23,607,128,509 +$638,048,061 $242.51 658
2021 Q4 94,533,097 $24,611,319,237 -$550,619,558 $260.48 703
2021 Q3 96,265,199 $25,370,506,829 -$115,406,017 $263.55 673
2021 Q2 96,700,199 $23,835,730,320 -$548,687,648 $246.52 650
2021 Q1 99,033,646 $19,213,495,080 -$384,053,397 $194.02 649
2020 Q4 101,297,957 $21,523,684,165 +$125,179,911 $212.56 652
2020 Q3 100,513,676 $17,230,325,953 -$286,391,481 $171.43 612
2020 Q2 102,006,987 $19,585,421,181 +$701,386,093 $192.00 567
2020 Q1 98,435,082 $14,502,972,264 +$119,165,301 $147.29 574
2019 Q4 97,640,442 $15,128,001,356 +$142,829,575 $154.97 551
2019 Q3 96,630,375 $13,051,505,290 +$38,434,738 $135.11 514
2019 Q2 96,365,742 $11,754,959,118 +$23,486,040 $122.03 475
2019 Q1 97,619,409 $10,147,859,923 -$14,207,588 $103.97 468
2018 Q4 97,569,996 $11,099,337,871 +$397,513,543 $113.87 489
2018 Q3 94,081,151 $10,848,844,708 +$178,170,189 $115.34 486
2018 Q2 92,503,328 $9,581,445,253 +$226,242,346 $103.58 455
2018 Q1 90,228,934 $8,883,079,877 +$143,625,612 $98.47 435
2017 Q4 89,322,328 $7,564,180,997 +$29,233,715 $84.69 410
2017 Q3 88,883,200 $6,839,668,471 +$166,333,622 $76.96 359
2017 Q2 86,773,703 $6,755,702,862 +$42,211,359 $77.87 335
2017 Q1 86,833,338 $6,248,639,244 +$813,666,355 $71.97 368
2016 Q4 88,072,867 $5,464,641,164 -$131,915,963 $62.05 356
2016 Q3 89,994,221 $5,828,633,461 +$197,606,819 $64.79 368
2016 Q2 86,958,278 $5,499,043,282 +$226,844,283 $63.23 355
2016 Q1 83,494,592 $4,825,081,452 +$24,464,544 $57.82 365
2015 Q4 82,814,635 $4,446,599,092 +$286,786,392 $53.69 346
2015 Q3 77,270,412 $3,927,210,578 +$122,197,423 $50.96 310
2015 Q2 74,586,620 $4,203,538,985 +$12,963,111 $56.37 310
2015 Q1 73,509,048 $5,271,836,683 -$59,419,105 $71.78 323
2014 Q4 74,749,965 $4,194,016,041 +$85,626,962 $56.06 302
2014 Q3 72,751,035 $3,584,815,417 -$144,765,288 $49.27 297
2014 Q2 75,588,962 $3,827,465,671 -$207,528,760 $50.63 308
2014 Q1 80,134,321 $3,581,405,050 +$1,484,371 $44.69 314